Status:
COMPLETED
Effect of Astaxanthin in Moderate to Severe Knee Osteoarthritis
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
40-90 years
Phase:
PHASE2
Brief Summary
This study will be 8 weeks randomized, double-blind, placebo-controlled trail to assess the effect of astaxanthin in 80 moderate to severe knee osteoarthritis patients. Participants will be assessed a...
Detailed Description
Osteoarthritis (OA) is the leading cause of disability worldwide and knee is the commonest joint involved. In 2020 there were around 654.1 million individuals (40 years and older) with knee OA and thi...
Eligibility Criteria
Inclusion
- Patients with knee pain
- Radiographic evidence of moderate to severe knee osteoarthritis
- Age 40 years or older
- Both male and female
Exclusion
- Prior history of knee trauma or surgery
- Previously diagnosed of systemic inflammatory conditions such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease
- Known allergy to fish or astaxanthin
- Currently taking immunosuppressant
- Pregnant and nursing mother
- Patients unwilling to participate or unwilling to give written consent
Key Trial Info
Start Date :
July 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05437601
Start Date
July 31 2022
End Date
December 19 2022
Last Update
April 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bangabandhu Sheikh Mujib Medical University
Dhaka, Bangladesh, 1000